Literature DB >> 34634124

Perspective: The High-Folate-Low-Vitamin B-12 Interaction Is a Novel Cause of Vitamin B-12 Depletion with a Specific Etiology-A Hypothesis.

Jacob Selhub, Joshua W Miller, Aron M Troen, Joel B Mason, Paul F Jacques.   

Abstract

Vitamin B-12 is a water-soluble vitamin that plays important roles in intermediary metabolism. Vitamin B-12 deficiency has many identifiable causes, including autoimmune and other gastrointestinal malabsorption disorders, dietary deficiency, and congenital defects in genes that are involved in vitamin B-12 trafficking and functions. Another putative cause of vitamin B-12 deficiency is the high-folate-low vitamin B-12 interaction, first suspected as the cause for observed relapse and exacerbation of the neurological symptoms in patients with pernicious anemia who were prescribed high oral doses of folic acid. We propose that this interaction is real and represents a novel cause of vitamin B-12 depletion with specific etiology. We hypothesize that excessive intake of folic acid depletes serum holotranscobalamin (holoTC), thereby decreasing active vitamin B-12 in the circulation and limiting its availability for tissues. This effect is specific for holoTC and does not affect holohaptocorrin, the inert form of serum vitamin B-12. Depletion of holoTC by folic acid in individuals with already low vitamin B-12 status further compromises the availability of vitamin B-12 coenzymes to their respective enzymes, and consequently a more pronounced state of biochemical deficiency. This hypothesis is drawn from evidence of observational and intervention studies of vitamin B-12-deficient patients and epidemiological cohorts. The evidence also suggests that, in a depleted state, vitamin B-12 is diverted to the hematopoietic system or the kidney. This most likely reflects a selective response of tissues expressing folate receptors with high affinity for unmetabolized folic acid (UMFA; e.g., hematopoietic progenitors and renal tubules) compared with those tissues (e.g., liver) that only express the reduced folate carrier, which is universally expressed but has poor affinity for UMFA. The biochemical and physiological mechanisms underlying this interaction require elucidation to clarify its potential public health significance.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  folate; folic acid; holotranscobalamin; homocysteine; methylmalonic acid; pernicious anemia; vitamin B-12

Mesh:

Substances:

Year:  2022        PMID: 34634124      PMCID: PMC8803489          DOI: 10.1093/advances/nmab106

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   11.567


  86 in total

1.  [Vitamin B12 content of blood during folic acid therapy of untreated patients with pernicious anemia].

Authors:  J BOK; H O NIEWEG; W F S KROESE; J G FABER; A DE VRIES
Journal:  Ned Tijdschr Geneeskd       Date:  1958-04-19

2.  Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification.

Authors:  Martha Savaria Morris; Paul F Jacques; Irwin H Rosenberg; Jacob Selhub
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

Review 3.  Receptor-Mediated Endocytosis in the Proximal Tubule.

Authors:  Megan L Eshbach; Ora A Weisz
Journal:  Annu Rev Physiol       Date:  2016-10-28       Impact factor: 19.318

Review 4.  The 1986 Herman award lecture. Nutrition science as a continually unfolding story: the folate and vitamin B-12 paradigm.

Authors:  V Herbert
Journal:  Am J Clin Nutr       Date:  1987-09       Impact factor: 7.045

5.  No reliable evidence that folate is harmful in B-12 deficiency.

Authors:  C J Dickinson
Journal:  BMJ       Date:  1995-10-07

6.  Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design.

Authors:  J D Spence; V J Howard; L E Chambless; M R Malinow; L C Pettigrew; M Stampfer; J F Toole
Journal:  Neuroepidemiology       Date:  2001-02       Impact factor: 3.282

7.  Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations.

Authors:  M R Malinow; P B Duell; M A Williams; W D Kruger; A A Evans; P H Anderson; P C Block; D L Hess; B M Upson; E E Graf; A Irvin-Jones; L Wang
Journal:  Lipids       Date:  2001       Impact factor: 1.880

8.  The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake.

Authors:  Steven W Bailey; June E Ayling
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

Review 9.  Absorption and blood/cellular transport of folate and cobalamin: Pharmacokinetic and physiological considerations.

Authors:  David H Alpers
Journal:  Biochimie       Date:  2015-11-14       Impact factor: 4.079

10.  Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases.

Authors:  Barbara Frigerio; Claudia Bizzoni; Gerrit Jansen; Christopher P Leamon; Godefridus J Peters; Philip S Low; Larry H Matherly; Mariangela Figini
Journal:  J Exp Clin Cancer Res       Date:  2019-03-12
View more
  1 in total

1.  Vitamin B-12.

Authors:  Agata Sobczyńska-Malefora; A David Smith
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.